Key Points
- CEO Roger Jeffs sold 18,839 shares on April 17 at $40.60 for $764,863, and after the transaction directly owns 1,423,095 shares (a 1.31% decline); the sale was executed under a pre-arranged Rule 10b5-1 trading plan.
- Jeffs conducted multiple sales earlier in April — a total of about 126,316 shares sold for roughly $5.02 million during the period — further reducing insider holdings.
- Liquidia shares opened down ~3.7% at $36.25; the company has a market cap of $3.19B, recently posted an earnings and revenue beat with revenue up 3,072% year-over-year, and carries an average analyst target of about $43.44 (consensus: Moderate Buy).
Liquidia Corporation (NASDAQ:LQDA - Get Free Report) CEO Roger Jeffs sold 18,839 shares of the company's stock in a transaction on Friday, April 17th. The stock was sold at an average price of $40.60, for a total transaction of $764,863.40. Following the completion of the transaction, the chief executive officer directly owned 1,423,095 shares of the company's stock, valued at $57,777,657. This represents a 1.31% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Roger Jeffs also recently made the following trade(s):
- On Wednesday, April 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $40.14, for a total transaction of $1,003,500.00.
- On Tuesday, April 14th, Roger Jeffs sold 3,300 shares of Liquidia stock. The stock was sold at an average price of $40.00, for a total transaction of $132,000.00.
- On Monday, April 13th, Roger Jeffs sold 32,744 shares of Liquidia stock. The stock was sold at an average price of $38.37, for a total transaction of $1,256,387.28.
- On Friday, April 10th, Roger Jeffs sold 21,433 shares of Liquidia stock. The stock was sold at an average price of $40.12, for a total transaction of $859,891.96.
- On Thursday, April 9th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $40.12, for a total transaction of $1,003,000.00.
Liquidia Trading Down 3.7%
Shares of Liquidia stock opened at $36.25 on Wednesday. The company has a market capitalization of $3.19 billion, a P/E ratio of -43.67 and a beta of 0.45. The company has a debt-to-equity ratio of 2.97, a quick ratio of 1.84 and a current ratio of 2.01. The company has a fifty day moving average of $36.37 and a 200 day moving average of $33.62. Liquidia Corporation has a fifty-two week low of $11.85 and a fifty-two week high of $46.67.
Liquidia (NASDAQ:LQDA - Get Free Report) last issued its earnings results on Thursday, March 5th. The company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.07. The company had revenue of $92.02 million during the quarter, compared to the consensus estimate of $87.49 million. Liquidia had a negative net margin of 43.53% and a negative return on equity of 209.33%. The company's quarterly revenue was up 3072.4% compared to the same quarter last year. On average, sell-side analysts anticipate that Liquidia Corporation will post 1.75 earnings per share for the current fiscal year.
Institutional Trading of Liquidia
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. purchased a new stake in Liquidia in the 4th quarter worth about $25,000. NewEdge Advisors LLC purchased a new stake in Liquidia in the 2nd quarter worth about $25,000. Skandinaviska Enskilda Banken AB publ purchased a new stake in Liquidia in the 3rd quarter worth about $30,000. FNY Investment Advisers LLC purchased a new stake in Liquidia in the 3rd quarter worth about $34,000. Finally, Covestor Ltd raised its position in Liquidia by 41.9% in the 4th quarter. Covestor Ltd now owns 1,216 shares of the company's stock worth $42,000 after purchasing an additional 359 shares during the period. 64.54% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several research firms have commented on LQDA. Raymond James Financial reissued a "strong-buy" rating on shares of Liquidia in a report on Thursday, March 5th. Wall Street Zen raised shares of Liquidia from a "hold" rating to a "buy" rating in a report on Saturday, March 7th. Lifesci Capital raised shares of Liquidia to a "strong-buy" rating in a report on Thursday, March 5th. Oppenheimer increased their price objective on shares of Liquidia from $16.00 to $19.00 and gave the company an "underperform" rating in a report on Thursday, March 12th. Finally, Jefferies Financial Group increased their price objective on shares of Liquidia from $45.00 to $55.00 and gave the company a "buy" rating in a report on Tuesday, January 13th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, one has given a Hold rating and two have given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $43.44.
Read Our Latest Research Report on Liquidia
About Liquidia
(
Get Free Report)
Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.
The company's lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
